nodes	percent_of_prediction	percent_of_DWPC	metapath
Bismuth Subsalicylate—PTGS2—bile duct cancer	0.905	1	CbGaD
Bismuth Subsalicylate—TF—bile—bile duct cancer	0.047	0.515	CbGeAlD
Bismuth Subsalicylate—TF—gall bladder—bile duct cancer	0.013	0.143	CbGeAlD
Bismuth Subsalicylate—ALB—gall bladder—bile duct cancer	0.00678	0.0743	CbGeAlD
Bismuth Subsalicylate—TF—pancreas—bile duct cancer	0.00601	0.0658	CbGeAlD
Bismuth Subsalicylate—TF—liver—bile duct cancer	0.00382	0.0419	CbGeAlD
Bismuth Subsalicylate—PTGS2—gall bladder—bile duct cancer	0.00369	0.0405	CbGeAlD
Bismuth Subsalicylate—TF—lymph node—bile duct cancer	0.00293	0.0321	CbGeAlD
Bismuth Subsalicylate—ALB—liver—bile duct cancer	0.00199	0.0218	CbGeAlD
Bismuth Subsalicylate—PTGS2—pancreas—bile duct cancer	0.0017	0.0187	CbGeAlD
Bismuth Subsalicylate—ALB—lymph node—bile duct cancer	0.00152	0.0167	CbGeAlD
Bismuth Subsalicylate—PTGS2—liver—bile duct cancer	0.00108	0.0119	CbGeAlD
Bismuth Subsalicylate—PTGS1—lymph node—bile duct cancer	0.000869	0.00952	CbGeAlD
Bismuth Subsalicylate—PTGS2—lymph node—bile duct cancer	0.000831	0.0091	CbGeAlD
Bismuth Subsalicylate—PTGS2—Signaling mediated by p38-alpha and p38-beta—KRT19—bile duct cancer	0.000275	0.0775	CbGpPWpGaD
Bismuth Subsalicylate—TF—Differentiation Pathway—HGF—bile duct cancer	0.000243	0.0686	CbGpPWpGaD
Bismuth Subsalicylate—TF—HIF-1-alpha transcription factor network—SMAD4—bile duct cancer	0.000194	0.0548	CbGpPWpGaD
Bismuth Subsalicylate—TF—Platelet degranulation—HGF—bile duct cancer	0.000161	0.0456	CbGpPWpGaD
Bismuth Subsalicylate—TF—Response to elevated platelet cytosolic Ca2+—HGF—bile duct cancer	0.000154	0.0434	CbGpPWpGaD
Bismuth Subsalicylate—TF—HIF-1-alpha transcription factor network—NOS2—bile duct cancer	0.000144	0.0408	CbGpPWpGaD
Bismuth Subsalicylate—TF—EPHB forward signaling—NRAS—bile duct cancer	0.000126	0.0355	CbGpPWpGaD
Bismuth Subsalicylate—TF—EPHB forward signaling—KRAS—bile duct cancer	0.000108	0.0306	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—bile duct cancer	0.000104	0.0294	CbGpPWpGaD
Bismuth Subsalicylate—TF—Differentiation Pathway—TGFB1—bile duct cancer	9.9e-05	0.028	CbGpPWpGaD
Bismuth Subsalicylate—TF—EPHB forward signaling—HRAS—bile duct cancer	9.2e-05	0.026	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Overview of nanoparticle effects—PTGS2—bile duct cancer	8.15e-05	0.023	CbGpPWpGaD
Bismuth Subsalicylate—TF—Differentiation Pathway—IL6—bile duct cancer	7.46e-05	0.0211	CbGpPWpGaD
Bismuth Subsalicylate—TF—Platelet activation, signaling and aggregation—HGF—bile duct cancer	7.16e-05	0.0202	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Eicosanoid Synthesis—PTGS2—bile duct cancer	6.76e-05	0.0191	CbGpPWpGaD
Bismuth Subsalicylate—TF—Platelet degranulation—TGFB1—bile duct cancer	6.58e-05	0.0186	CbGpPWpGaD
Bismuth Subsalicylate—TF—Response to elevated platelet cytosolic Ca2+—TGFB1—bile duct cancer	6.27e-05	0.0177	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—bile duct cancer	5.66e-05	0.016	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Signaling mediated by p38-alpha and p38-beta—NOS2—bile duct cancer	5.4e-05	0.0152	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—FAR2—bile duct cancer	4.65e-05	0.0131	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Overview of nanoparticle effects—IL6—bile duct cancer	4.44e-05	0.0125	CbGpPWpGaD
Bismuth Subsalicylate—TF—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	4.32e-05	0.0122	CbGpPWpGaD
Bismuth Subsalicylate—TF—Hemostasis—GNAS—bile duct cancer	3.87e-05	0.0109	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Arachidonic acid metabolism—PTGS2—bile duct cancer	3.76e-05	0.0106	CbGpPWpGaD
Bismuth Subsalicylate—TF—Hemostasis—HGF—bile duct cancer	3.69e-05	0.0104	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—FAR2—bile duct cancer	3.69e-05	0.0104	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Overview of nanoparticle effects—IL6—bile duct cancer	3.53e-05	0.00996	CbGpPWpGaD
Bismuth Subsalicylate—TF—Transmembrane transport of small molecules—GNAS—bile duct cancer	3.35e-05	0.00947	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—FAR2—bile duct cancer	2.99e-05	0.00843	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet degranulation—HGF—bile duct cancer	2.94e-05	0.00831	CbGpPWpGaD
Bismuth Subsalicylate—TF—Platelet activation, signaling and aggregation—TGFB1—bile duct cancer	2.92e-05	0.00824	CbGpPWpGaD
Bismuth Subsalicylate—TF—SIDS Susceptibility Pathways—IL6—bile duct cancer	2.91e-05	0.00821	CbGpPWpGaD
Bismuth Subsalicylate—TF—Hemostasis—NOS2—bile duct cancer	2.83e-05	0.00799	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Response to elevated platelet cytosolic Ca2+—HGF—bile duct cancer	2.8e-05	0.00791	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Aryl Hydrocarbon Receptor—NRAS—bile duct cancer	2.48e-05	0.00701	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Selenium Micronutrient Network—PTGS2—bile duct cancer	2.39e-05	0.00676	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—bile duct cancer	2.36e-05	0.00667	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Aryl Hydrocarbon Receptor—EGFR—bile duct cancer	2.26e-05	0.00639	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Aryl Hydrocarbon Receptor—KRAS—bile duct cancer	2.14e-05	0.00603	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—FAR2—bile duct cancer	2.07e-05	0.00585	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—NOS2—bile duct cancer	2.04e-05	0.00577	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—IDH1—bile duct cancer	1.95e-05	0.00551	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—SMAD4—bile duct cancer	1.87e-05	0.00527	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Aryl Hydrocarbon Receptor—HRAS—bile duct cancer	1.82e-05	0.00513	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—FAR2—bile duct cancer	1.64e-05	0.00464	CbGpPWpGaD
Bismuth Subsalicylate—TF—Hemostasis—NRAS—bile duct cancer	1.62e-05	0.00457	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism of lipids and lipoproteins—IDH1—bile duct cancer	1.55e-05	0.00438	CbGpPWpGaD
Bismuth Subsalicylate—ALB—SLC-mediated transmembrane transport—SLC5A5—bile duct cancer	1.55e-05	0.00437	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Selenium Micronutrient Network—PTGS2—bile duct cancer	1.54e-05	0.00434	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—C-MYB transcription factor network—NRAS—bile duct cancer	1.53e-05	0.00433	CbGpPWpGaD
Bismuth Subsalicylate—TF—Hemostasis—TGFB1—bile duct cancer	1.5e-05	0.00425	CbGpPWpGaD
Bismuth Subsalicylate—TF—Hemostasis—KRAS—bile duct cancer	1.39e-05	0.00394	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—FAR2—bile duct cancer	1.33e-05	0.00375	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—C-MYB transcription factor network—KRAS—bile duct cancer	1.32e-05	0.00373	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—MMP9—bile duct cancer	1.32e-05	0.00372	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—HGF—bile duct cancer	1.3e-05	0.00368	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Selenium Micronutrient Network—IL6—bile duct cancer	1.3e-05	0.00368	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Vitamin B12 Metabolism—IL6—bile duct cancer	1.3e-05	0.00366	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—IDH1—bile duct cancer	1.25e-05	0.00354	CbGpPWpGaD
Bismuth Subsalicylate—TF—Hemostasis—TP53—bile duct cancer	1.24e-05	0.0035	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet degranulation—TGFB1—bile duct cancer	1.2e-05	0.00339	CbGpPWpGaD
Bismuth Subsalicylate—TF—Hemostasis—HRAS—bile duct cancer	1.18e-05	0.00334	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Folate Metabolism—TP53—bile duct cancer	1.15e-05	0.00325	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—bile duct cancer	1.14e-05	0.00323	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—C-MYB transcription factor network—HRAS—bile duct cancer	1.12e-05	0.00317	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—TGFB1—bile duct cancer	1.09e-05	0.00307	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—EGFR—bile duct cancer	1.06e-05	0.00301	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Folate Metabolism—IL6—bile duct cancer	1.05e-05	0.00298	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—bile duct cancer	1.04e-05	0.00295	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Selenium Micronutrient Network—IL6—bile duct cancer	1.03e-05	0.00292	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—IDH2—bile duct cancer	1.01e-05	0.00285	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—RNF43—bile duct cancer	9.58e-06	0.00271	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—TP53—bile duct cancer	8.94e-06	0.00252	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—IDH1—bile duct cancer	8.69e-06	0.00245	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Selenium Micronutrient Network—IL6—bile duct cancer	8.37e-06	0.00236	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—IDH1—bile duct cancer	8.24e-06	0.00233	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Spinal Cord Injury—IL6—bile duct cancer	8.18e-06	0.00231	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—IDH2—bile duct cancer	8.03e-06	0.00227	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	7.86e-06	0.00222	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—bile duct cancer	7.39e-06	0.00209	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—bile duct cancer	7.24e-06	0.00205	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—GNAS—bile duct cancer	7.06e-06	0.00199	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—IDH1—bile duct cancer	6.9e-06	0.00195	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—bile duct cancer	6.84e-06	0.00193	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—HGF—bile duct cancer	6.73e-06	0.0019	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—IDH2—bile duct cancer	6.49e-06	0.00183	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Transmembrane transport of small molecules—GNAS—bile duct cancer	6.11e-06	0.00173	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—bile duct cancer	6.08e-06	0.00172	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—SLC5A5—bile duct cancer	5.74e-06	0.00162	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—IDH1—bile duct cancer	5.58e-06	0.00158	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	5.37e-06	0.00152	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Platelet activation, signaling and aggregation—TGFB1—bile duct cancer	5.32e-06	0.0015	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—NOS2—bile duct cancer	5.16e-06	0.00146	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—SLC5A5—bile duct cancer	4.55e-06	0.00129	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—GNAS—bile duct cancer	4.46e-06	0.00126	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—TGFBR2—bile duct cancer	4.38e-06	0.00124	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—SMAD4—bile duct cancer	4.15e-06	0.00117	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—SLC5A5—bile duct cancer	3.68e-06	0.00104	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Metabolism—GNAS—bile duct cancer	3.54e-06	0.000999	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	3.45e-06	0.000975	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—NOS2—bile duct cancer	3.09e-06	0.000871	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—NRAS—bile duct cancer	2.95e-06	0.000833	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—GNAS—bile duct cancer	2.86e-06	0.000808	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—TGFB1—bile duct cancer	2.74e-06	0.000774	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—KRAS—bile duct cancer	2.54e-06	0.000717	CbGpPWpGaD
Bismuth Subsalicylate—PTGS1—Metabolism—PTGS2—bile duct cancer	2.39e-06	0.000676	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—ERBB2—bile duct cancer	2.32e-06	0.000655	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—TP53—bile duct cancer	2.26e-06	0.000637	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Hemostasis—HRAS—bile duct cancer	2.16e-06	0.000609	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—NRAS—bile duct cancer	1.77e-06	0.000498	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—TGFB1—bile duct cancer	1.64e-06	0.000463	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—EGFR—bile duct cancer	1.61e-06	0.000454	CbGpPWpGaD
Bismuth Subsalicylate—ALB—Metabolism—PTGS2—bile duct cancer	1.54e-06	0.000434	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—KRAS—bile duct cancer	1.52e-06	0.000429	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—HRAS—bile duct cancer	1.29e-06	0.000365	CbGpPWpGaD
Bismuth Subsalicylate—PTGS2—Disease—IL6—bile duct cancer	1.24e-06	0.000349	CbGpPWpGaD
